Previous story: BD India and Dr Lal PathLabs launch best practices in phlebotomy to reduce lab errors and improve patient outcomes Next story: Hyderabad : The Cyient Foundation (the CSR arm of Cyient Ltd.) signed a memorandum of understanding ... APN News, 1 week ago
BD India and Dr Lal PathLabs launch COE in phlebotomy - Financial Express, 1 week ago
Dr Lal PathLabs & BD Collaborate to Drive Best Practices in Phlebotomy Healthcare Workers to Receive Certified Training on Safe Blood Collection Practices - Web Newswire, 2 weeks ago
1 images for "dr lal pathlabs"
By Biswarup Gooptu , ET Bureau | 11 May, 2015, 03.56AM IST Post a Comment NEW DELHI: Diagnostics and pathology services company Dr Lal PathLabs has mandated investment banks Kotak Investment Bank and Citi Investment Bank to lead its initial public offering, ...Economic Times, 1 month ago Kotak, Citi to lead Dr PathLabs public offer Economic Times, 1 month ago Kotak, Citi Investment Bank to lead Dr Lal PathLabs IPO Economic Times, 1 month ago
A file photo of Om Manchanda, chief executive officer at Dr Lal PathLabs. Post-IPO, Dr Lal PathLabs will be valued at nearly Rs. 6,000 crore, said a banker familiar with the development. Photo: Priyanka Parashar/Mint Mumbai: Diagnostic and ...Livemint.com, 1 month ago Dr Lal PathLabs kicks off IPO: report M&A Portal, 1 month ago Dr Lal PathLabs begins IPO process to raise Rs 700 crore MSN News US, 1 month ago
nd Mahajan Imaging, according to former athlete Gurbachan Singh Randhawa. Randhawa, India's legendary athlete, who finished fifth at the 1964 Tokyo Olympics, said that he convinced the two companies to offer discount to sportspersons. "I met Dr Arvind Lal of, ...Business Standard, 1 month ago
MUMBAI/CHENNAI: The boardroom tussle in one of the country's leading diagnostics chain Metropolis Healthcare is possibly ending with estranged co-promoter GSK Velu selling his 37% stake to private equity giant Carlyle Group for more than Rs 900 ...Times of India, 2 days ago
BANGALORE: Private equity major TA Associates is leading a $500-million, or Rs 3,000 crore, acquisition of Atria Convergence Technologies (ACT), one of the country's leading high-speed broadband service providers headquartered in Bangalore. TA ...Times of India, 2 days ago US fund TA leads Rs 3,000 crore broadband co Atria buyout Economic Times, 1 day ago
The second edition of BW Healthcare Summit held in New Delhi on June 5 attracted major healthcare industry players. Dr Om Manchanda, chief executive officer of Dr Lal PathLabs, was among those who spoke at the event. He talked to Haider Ali Khan ...Businessworld India, 3 weeks ago
Given that Sebi is aware of CEO Velumani's issuing shares to employees and relatives, it would take some action against the company before approving the IPO document, say experts. The initial public offer (IPO) plan of Thyrocare Technologies Ltd, ...Livemint.com, 1 month ago Thyrocare Technologies' IPO plan hits Sebi roadblock [Mint, New Delhi] Bloomberg, 1 month ago
NEW DELHI: The Centre is set to announce a scheme for providing free diagnostic tests, including several blood tests, x-rays and advanced CT scans, for those visiting public health facilities. Private service providers will be roped in wherever ...Times of India, 1 month ago Government to provide free diagnostic tests for all Economic Times, 1 month ago
on your WebpageAdd Widget >Get your members hooked!